Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-09-13 5:54 pm Purchase | 2024-09-11 | 13D | Summit Therapeutics Inc. SMMT | DUGGAN ROBERT W | 555,736,060 75.200% | 379,871,779 (+216.00%) | Filing History |
| 2023-03-13 4:51 pm Purchase | 2023-03-08 | 13D | Summit Therapeutics Inc. SMMT | Zanganeh Mahkam | 36,882,393 5.270% | 31,399,111 (+572.63%) | Filing History |
| 2023-02-16 4:01 pm Unchanged | 2023-02-07 | 13D | Summit Therapeutics Inc. SMMT | DUGGAN ROBERT W | 175,864,281 78.100% | 0 (Unchanged) | Filing History |
| 2023-02-14 4:03 pm Sale | 2022-12-31 | 13G | Summit Therapeutics Inc. SMMT | Polar Capital Holdings Plc | 0 0.000% | -6,295,713 (Position Closed) | Filing History |
| 2022-12-09 5:24 pm Purchase | 2022-12-06 | 13D | Summit Therapeutics Inc. SMMT | DUGGAN ROBERT W | 175,864,281 81.800% | 9,346,434 (+5.61%) | Filing History |
| 2022-08-18 4:43 pm Purchase | 2022-08-16 | 13D | Summit Therapeutics Inc. SMMT | DUGGAN ROBERT W | 166,517,847 81.150% | 94,870,338 (+132.41%) | Filing History |
| 2022-02-14 10:47 am Purchase | 2021-12-31 | 13G | Summit Therapeutics Inc. SMMT | Polar Capital Holdings Plc | 6,295,713 6.400% | 495,713 (+8.55%) | Filing History |
| 2021-05-14 4:27 pm Purchase | 2021-05-12 | 13D | Summit Therapeutics Inc. SMMT | DUGGAN ROBERT W | 71,647,509 70.780% | 11,365,921 (+18.85%) | Filing History |
| 2021-04-22 5:11 pm Unchanged | 2021-04-20 | 13D | Summit Therapeutics Inc. SMMT | DUGGAN ROBERT W | 60,281,588 69.370% | 0 (Unchanged) | Filing History |
| 2021-03-26 5:07 pm Unchanged | 2021-03-24 | 13D | Summit Therapeutics Inc. SMMT | DUGGAN ROBERT W | 60,281,588 69.370% | 0 (Unchanged) | Filing History |
| 2021-02-16 07:32 am Purchase | 2020-12-31 | 13G | Summit Therapeutics Inc. SMMT | Polar Capital Holdings Plc | 5,800,000 7.050% | 5,800,000 (New Position) | Filing History |